View as a web page <[[[link removed]]]>
${newsletterName}
${newsletterDate}

${newsletterSubtitle}
${article01TitleText} <[[${article01URL}]]>
${article01Credit}
At this stage in the crisis, it seems that many key officials are doing many important things right yet they also have to work around some serious decisional dysfunction at the top, explains Yuval Levin.
${buttonText} <[[${article01URL}]]>

<[link removed]>
<[link removed]>
${article01TitleText} <[[${article01URL}]]>
${article01Credit}
Kori Schake gives some guidelines of things the president and Defense Department should do — and avoid doing — to ensure that they don’t create dangerous precedents in American civil-military relations.
${buttonText} <[[${article01URL}]]>

<[link removed]>
<[link removed]>
${article01TitleText} <[[${article01URL}]]>
${article01Credit}
Scott Gottlieb and Luciana Borio write that Italy and China proved that the only way to save lives is to make sure the medical system can keep pace with the need for critical care.
${buttonText} <[[${article01URL}]]>

<[link removed]>
<[link removed]>
${article01TitleText} <[[${article01URL}]]>
${article01Credit}
Over the past 15 years, airlines have become more apt to compete head-to-head over routes, making air travel more affordable even as the number of airlines has decreased, write Scott Ganz and Burke O'Brien. The data make a compelling case that competition among airlines was stronger than ever before the COVID-19 pandemic.
${buttonText} <[[${article01URL}]]>

<[link removed]>
<[link removed]>
${article01TitleText} <[[${article01URL}]]>
${article01Credit}
The 2016 election confirmed the reformocon analysis of Republican politics while removing some of the barriers to the pursuit of reform. The question is not whether reform conservatism has a future. It is what shape that future will take, writes Matthew Continetti.
${buttonText} <[[${article01URL}]]>

<[link removed]>
<[link removed]>

<[link removed]>
<[link removed]>
research spotlight
${article01TitleText} <[[${article01URL}]]>
${article01Credit}
We need to determine which treatments work best to advance safe and effective products to market efficiently and to enable access to promising treatments for patients who might benefit from them now, explain Scott Gottlieb and Mark McClellan.

<[link removed]>
<[link removed]>
Donate to AEI <[link removed]> in support of defending and promoting freedom, opportunity, and enterprise.

AEI cares about your inbox. Want to tailor your AEI subscriptions? Click here <[link removed]> and get content that matters to you.


View online <[[[link removed]]]> | Ensure
delivery <[link removed]> | Subscribe <[link removed]>



American Enterprise Institute
1789 Massachusetts Avenue, NW, Washington, DC 20036
202.862.5800 <[link removed]> | www.aei.org <[link removed]>  



<[link removed]>   <[link removed]>   <[link removed]>   <[link removed]>    <[link removed]>   <[link removed]>

This message is for: [email protected] <mailto:[email protected]> | Manage Preferences <[link removed]> | Unsubscribe <[link removed]>